Document



SCHEDULE 14A INFORMATION
Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934
(Amendment No. )

Filed by the Registrant ☒    Filed by a Party other than the Registrant
Check the appropriate box:
Preliminary Proxy Statement
Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
Definitive Proxy Statement
☒    Definitive Additional Materials
Soliciting Material under 240.14a-12

BELLICUM PHARMACEUTICALS, INC.

https://cdn.kscope.io/6e0b625a1d3a519fea8f5765d27a2179-image_0a.jpg
(Name of Registrant as Specified In Its Charter)

https://cdn.kscope.io/6e0b625a1d3a519fea8f5765d27a2179-image_0a.jpg
(Name of Person(s) Filing Proxy Statement if Other Than the Registrant)

Payment of Filing Fee (Check the appropriate box):
☒    No fee required.
Fee paid previously with preliminary materials.
Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11.




https://cdn.kscope.io/6e0b625a1d3a519fea8f5765d27a2179-imagea.jpg



https://cdn.kscope.io/6e0b625a1d3a519fea8f5765d27a2179-image1a.jpg